These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of periodontal status in subjects with hyperlipidemia. Awartani F, Atassi F. J Contemp Dent Pract; 2010 Mar 01; 11(2):033-40. PubMed ID: 20228985 [Abstract] [Full Text] [Related]
4. Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment. Fentoğlu O, Sözen T, Oz SG, Kale B, Sönmez Y, Tonguç MO, Gürgan CA, Aykaç Y, Kirzioğlu FY. Oral Dis; 2010 Oct 01; 16(7):648-54. PubMed ID: 20412449 [Abstract] [Full Text] [Related]
5. Periodontal status in subjects with hyperlipidemia and determination of association between hyperlipidemia and periodontal health: a clinicobiochemical study. Shivakumar T, Patil VA, Desai MH. J Contemp Dent Pract; 2013 Sep 01; 14(5):785-9. PubMed ID: 24685775 [Abstract] [Full Text] [Related]
6. Serum lipoprotein-associated phospholipase A₂ and C-reactive protein levels in association with periodontal disease and hyperlipidemia. Fentoğlu O, Köroğlu BK, Kara Y, Doğan B, Yılmaz G, Sütçü R, Ay ZY, Tonguç MÖ, Orhan H, Tamer MN, Kırzıoğlu FY. J Periodontol; 2011 Mar 01; 82(3):350-9. PubMed ID: 20809860 [Abstract] [Full Text] [Related]
7. Clinical periodontal and microbiologic parameters in patients with acute myocardial infarction. Stein JM, Kuch B, Conrads G, Fickl S, Chrobot J, Schulz S, Ocklenburg C, Smeets R. J Periodontol; 2009 Oct 01; 80(10):1581-9. PubMed ID: 19792846 [Abstract] [Full Text] [Related]
8. Periodontal status in subjects with hyperlipidemia. Fentoğlu O, Oz G, Taşdelen P, Uskun E, Aykaç Y, Bozkurt FY. J Periodontol; 2009 Feb 01; 80(2):267-73. PubMed ID: 19186967 [Abstract] [Full Text] [Related]
9. Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers. Magán-Fernández A, Papay-Ramírez L, Tomás J, Marfil-Álvarez R, Rizzo M, Bravo M, Mesa F. J Periodontol; 2014 Oct 01; 85(10):1408-15. PubMed ID: 24555750 [Abstract] [Full Text] [Related]
14. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation. Demetriou D, Shabpar A, Böhmig G, Schmaldienst S, Hörl WH, Watschinger B. Wien Klin Wochenschr; 2000 Apr 21; 112(8):358-61. PubMed ID: 10849941 [Abstract] [Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP. Am J Geriatr Pharmacother; 2007 Sep 21; 5(3):185-94. PubMed ID: 17996658 [Abstract] [Full Text] [Related]
16. Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment. Fentoğlu O, Kirzioğlu FY, Ozdem M, Koçak H, Sütçü R, Sert T. Oral Dis; 2012 Apr 21; 18(3):299-306. PubMed ID: 22151458 [Abstract] [Full Text] [Related]
17. Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients. Soran H, France MW, Kwok S, Dissanayake S, Charlton-Menys V, Younis NN, Durrington PN. Ann Clin Biochem; 2011 Nov 21; 48(Pt 6):566-71. PubMed ID: 22006975 [Abstract] [Full Text] [Related]
18. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H, Akcay A, Ozdemir FN. Ren Fail; 2005 Nov 21; 27(3):297-303. PubMed ID: 15957546 [Abstract] [Full Text] [Related]
19. Changes in inflammatory and metabolic parameters after periodontal treatment in patients with and without obesity. Altay U, Gürgan CA, Ağbaht K. J Periodontol; 2013 Jan 21; 84(1):13-23. PubMed ID: 22348694 [Abstract] [Full Text] [Related]